Sensei Biotherapeutics, Inc.

Related Filers (27)

News (44)

8-K
Thursday, 2/8/2024
Current report filing
8-K
Thursday, 1/4/2024
Current report filing
8-K
Tuesday, 11/7/2023
Current report filing
8-K
Monday, 11/6/2023
Current report filing
8-K
Friday, 11/3/2023
Current report filing
8-K
Friday, 10/20/2023
Current report filing
8-K
Thursday, 8/3/2023
Current report filing
8-K
Monday, 7/10/2023
Current report filing
8-K
Tuesday, 6/27/2023
Current report filing
8-K
Friday, 6/23/2023
Current report filing
8-K
Tuesday, 5/23/2023
Current report filing
8-K
Tuesday, 5/9/2023
Current report filing
8-K
Thursday, 4/20/2023
Current report filing
8-K
Tuesday, 3/28/2023
Current report filing
8-K
Monday, 3/13/2023
Current report filing
8-K
Friday, 3/10/2023
Current report filing
8-K
Tuesday, 3/7/2023
Current report filing
8-K
Monday, 2/6/2023
Current report filing
8-K
Friday, 12/9/2022
Current report filing
8-K
Thursday, 12/8/2022
Current report filing
8-K
Thursday, 11/10/2022
Current report filing
8-K
Tuesday, 11/8/2022
Current report filing
8-K
Friday, 9/30/2022
Current report filing
8-K
Wednesday, 8/31/2022
Current report filing
8-K
Tuesday, 8/9/2022
Current report filing
8-K
Tuesday, 6/14/2022
Current report filing
8-K
Tuesday, 5/10/2022
Current report filing
8-K
Wednesday, 4/20/2022
Current report filing
8-K
Thursday, 3/10/2022
Current report filing
8-K
Wednesday, 3/9/2022
Current report filing
8-K
Monday, 1/10/2022
Current report filing
8-K
Monday, 12/6/2021
Current report filing
8-K
Tuesday, 11/16/2021
Current report filing
8-K
Tuesday, 11/9/2021
Current report filing
8-K
Wednesday, 9/8/2021
Current report filing
8-K
Wednesday, 8/4/2021
Current report filing
8-K
Monday, 8/2/2021
Current report filing
8-K
Monday, 6/28/2021
Current report filing
8-K
Thursday, 6/17/2021
Current report filing
8-K
Wednesday, 5/12/2021
Current report filing
8-K
Monday, 5/3/2021
Current report filing
8-K
Monday, 4/5/2021
Current report filing
8-K
Thursday, 3/25/2021
Current report filing
8-K
Thursday, 2/11/2021
Current report filing
Show More

Other (14)

ARS
Thursday, 6/15/2023
Annual report to security holders
8-A12B
Tuesday, 3/7/2023
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
EFFECT
Monday, 5/9/2022
Notice of Effectiveness
CORRESP
Friday, 5/6/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 5/6/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 5/4/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CERT
Wednesday, 2/3/2021
Certification by an exchange approving securities for listing
EFFECT
Wednesday, 2/3/2021
Notice of Effectiveness
8-A12B
Tuesday, 2/2/2021
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Monday, 2/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 2/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 1/22/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 1/15/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Tuesday, 12/29/2020
None
Show More

Ownership (195)

4
Friday, 2/16/2024
van der Horst Edward: Statement of changes in beneficial ownership of securities
4
Friday, 2/16/2024
Colgan Erin: Statement of changes in beneficial ownership of securities
4
Friday, 2/16/2024
Celebi John: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 2/13/2024
Newtyn Management, LLC: Major Shareholders
SC 13D
Friday, 11/3/2023
Newtyn Management, LLC: Major Shareholders
3
Thursday, 11/2/2023
Krebs Stephanie: Initial statement of beneficial ownership of securities
4
Thursday, 11/2/2023
Krebs Stephanie: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/13/2023
Celebi John: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2023
Gallagher Patrick Stephen: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2023
van der Horst Edward: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2023
Celebi John: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2023
Colgan Erin: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 8/4/2023
Cambrian BioPharma Inc: Major Shareholders
4
Wednesday, 8/2/2023
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/2/2023
Peyer James: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Broder Samuel: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
RICKS THOMAS G: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
RINGO WILLIAM R: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Vojta Deneen: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Humer Kristian: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Peyer James: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Holmen Bob: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
English Jessie: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 6/2/2023
Apeiron Investment Group Ltd.: Major Shareholders
4
Friday, 6/2/2023
Presight Sensei Co-Invest Fund, L.P.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 5/23/2023
Apeiron Investment Group Ltd.: Major Shareholders
4/A
Wednesday, 3/29/2023
Gallagher Patrick Stephen: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 3/29/2023
Celebi John: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 3/29/2023
Colgan Erin: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 3/9/2023
Apeiron Investment Group Ltd.: Major Shareholders
4/A
Tuesday, 3/7/2023
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2023
Presight Sensei Co-Invest Fund, L.P.: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
Celebi John: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
Gallagher Patrick Stephen: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
van der Horst Edward: Statement of changes in beneficial ownership of securities
4
Friday, 2/17/2023
Colgan Erin: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Cambrian BioPharma Inc: Major Shareholders
3
Friday, 12/16/2022
van der Horst Edward: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 11/21/2022
Apeiron Investment Group Ltd.: Major Shareholders
SC 13D/A
Wednesday, 11/2/2022
Apeiron Investment Group Ltd.: Major Shareholders
4/A
Thursday, 9/1/2022
Pierce Robert Hamilton: Statement of changes in beneficial ownership of securities
4/A
Monday, 8/1/2022
Peyer James: Statement of changes in beneficial ownership of securities
3/A
Monday, 8/1/2022
Peyer James: Initial statement of beneficial ownership of securities
3
Wednesday, 7/20/2022
Apeiron Investment Group Ltd.: Initial statement of beneficial ownership of securities
SC 13D
Tuesday, 7/19/2022
Apeiron Investment Group Ltd.: Major Shareholders
4
Tuesday, 6/14/2022
RICKS THOMAS G: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Holmen Bob: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
English Jessie: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Vojta Deneen: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Humer Kristian: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Broder Samuel: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4/A
Friday, 6/10/2022
Peyer James: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 6/10/2022
Cambrian BioPharma Inc: Major Shareholders
4/A
Friday, 6/10/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
Gallagher Patrick Stephen: Statement of changes in beneficial ownership of securities
3
Friday, 6/3/2022
Gallagher Patrick Stephen: Initial statement of beneficial ownership of securities
4/A
Thursday, 4/21/2022
Peyer James: Statement of changes in beneficial ownership of securities
4/A
Thursday, 4/21/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4/A
Thursday, 4/21/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4/A
Thursday, 4/21/2022
Peyer James: Statement of changes in beneficial ownership of securities
3
Wednesday, 3/9/2022
RINGO WILLIAM R: Initial statement of beneficial ownership of securities
4
Wednesday, 3/9/2022
RINGO WILLIAM R: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/1/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/1/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Monday, 2/28/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Monday, 2/28/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 2/24/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 2/24/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/22/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/22/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 2/17/2022
Pierce Robert Hamilton: Statement of changes in beneficial ownership of securities
4
Thursday, 2/17/2022
Celebi John: Statement of changes in beneficial ownership of securities
4
Thursday, 2/17/2022
Colgan Erin: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/16/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/16/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Monday, 2/14/2022
Peyer James: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 2/14/2022
H INVESTMENTS I LP: Major Shareholders
4
Monday, 2/14/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/10/2022
Apeiron Investment Group Ltd.: Major Shareholders
4
Tuesday, 2/8/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/8/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Monday, 1/31/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Monday, 1/31/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 1/27/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 1/27/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/25/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/25/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 1/20/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 1/20/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/18/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/18/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Peyer James: Statement of changes in beneficial ownership of securities
4
Thursday, 1/13/2022
Cambrian BioPharma Inc: Statement of changes in beneficial ownership of securities
Show More

Prospectus (14)

424B5
Thursday, 8/17/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Wednesday, 3/29/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Tuesday, 5/10/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Monday, 5/9/2022
Prospectus filed pursuant to Rule 424(b)(5)
S-3/A
Monday, 5/9/2022
Registration statement for specified transactions by certain issuers
S-3
Tuesday, 3/15/2022
Registration statement for specified transactions by certain issuers
S-8
Wednesday, 2/10/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Thursday, 2/4/2021
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Wednesday, 2/3/2021
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Monday, 2/1/2021
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 1/15/2021
General form of registration statement for all companies including face-amount certificate companies
DRSLTR
Tuesday, 12/22/2020
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 12/22/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Thursday, 11/12/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Show More

Proxies (6)

DEF 14A
Thursday, 6/15/2023
Definitive proxy statements
DEFA14A
Tuesday, 5/23/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Friday, 3/10/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Thursday, 4/28/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Thursday, 4/28/2022
Definitive proxy statements
DEFA14A
Thursday, 4/28/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
Show More